CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 53 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $5,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | -37.5% | 2,000 | 0.0% | 0.00% | – |
| Q4 2017 | $8,000 | +60.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2017 | $5,000 | -16.7% | 2,000 | 0.0% | 0.00% | – |
| Q2 2017 | $6,000 | +50.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2017 | $4,000 | +100.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -50.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | -60.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2015 | $5,000 | -16.7% | 2,000 | 0.0% | 0.00% | – |
| Q3 2015 | $6,000 | -25.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2015 | $8,000 | -38.5% | 2,000 | -33.3% | 0.00% | – |
| Q1 2015 | $13,000 | -7.1% | 3,000 | -45.5% | 0.00% | – |
| Q2 2014 | $14,000 | +16.7% | 5,500 | 0.0% | 0.00% | – |
| Q1 2014 | $12,000 | -29.4% | 5,500 | 0.0% | 0.00% | -100.0% |
| Q3 2013 | $17,000 | – | 5,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,097,300 | $27,750,000 | 4.54% |
| GREAT POINT PARTNERS LLC | 3,817,288 | $14,926,000 | 2.55% |
| TANAKA CAPITAL MANAGEMENT INC | 256,593 | $1,003,000 | 2.29% |
| Consonance Capital Management LP | 4,473,607 | $17,492,000 | 1.58% |
| Avoro Capital Advisors LLC | 3,892,343 | $15,219,000 | 0.99% |
| KNOTT DAVID M | 380,110 | $1,486,000 | 0.59% |
| EAM Investors, LLC | 790,872 | $3,092,000 | 0.55% |
| Ghost Tree Capital, LLC | 550,000 | $2,151,000 | 0.50% |
| EAM Global Investors LLC | 251,647 | $984,000 | 0.50% |
| MANGROVE PARTNERS IM, LLC | 924,648 | $3,615,000 | 0.49% |